Telix Pharmaceuticals Limited
Talk to Telix Pharmaceuticals Limited directly.
Sign up to their Investor Hub for direct access to the Telix Pharmaceuticals Limited team, ask them questions, and see personal updates.
Telix Pharmaceuticals Limited (TLX) is a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or molecularly-targeted radiation" (MTR). The company is headquartered in Melbourne with international operations in Brussels (EU), Kyoto (JP) and Indianapolis (US). Telix is developing a portfolio of clinical-stage oncology products that address significant unmet medical need in renal, prostate and brain (glioblastoma) cancer.
401/55 Flemington Rd, Parkville VIC 3052, Australia
Earnings per share
Dividend per share